ProfileGDS4177 / 1557458_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 63% 64% 58% 68% 71% 77% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated62.0963
GSM603099KU-812 non-treated65.4464
GSM603098KCL-22 Imatinib-treated47.1858
GSM603097KCL-22 non-treated85.468
GSM603102JURL-MK1 Imatinib-treated106.9471
GSM603101JURL-MK1 non-treated158.1577